Rapid-paced innovation are creating opportunities for companies to improve the health and lives of Canadians every day. Often though, companies meet challenges along the way – regulatory, policy, stakeholder or legislative barriers that aren’t keeping pace with today’s changing environment. Earnscliffe has a long history of work in the field beginning with the formation of the Canadian Biotechnology Secretariat in the mid 1990s. We advised government on its biotechnology strategy and produced the world’s largest public opinion data base on biotechnology. Ever since, Earnscliffe has worked with clients in the biotechnology and life sciences sector – research organizations, incubators, pharmaceutical companies and industry associations – to develop advocacy and deliver compelling narratives to decision-makers and beneficiaries of the innovations they bring to the marketplace.